ALECTOR INC. - COMMON STOCK
4,9200
27-сентября-24 14:59:58
15 мин. задержка
Акции
+0,1100
+2,29%
Сегодняшний диапазон
4,7700 - 5,0100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Alector to Participate in the Stifel Healthcare Conference
08 ноя 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
07 ноя 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
27 окт 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
07 сен 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
31 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
03 авг 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
Alector to Host Mid-Year Earnings Conference Call
27 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
06 июн 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
04 май 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Alector to Participate in the BofA Securities 2023 Healthcare Conference
02 май 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
01 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
28 фев 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 дек 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
29 ноя 2022 10:05:00 Источник Nasdaq GlobeNewswire
-
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
08 ноя 2022 15:05:01 Источник Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
07 ноя 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 ноя 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Alector Announces Promotion of Clare Hunt to Chief People Officer
13 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 окт 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)
12 сен 2022 06:00:00 Источник Nasdaq GlobeNewswire